[CMSB] QoQ TTM Result on 30-Sep-2014 [#3]

Stock
[CMSB] CAHYA MATA SARAWAK BHD
Announcement Date
26-Nov-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Sep-2014 [#3]
Profit Trend
QoQ- 14.85%
YoY- 67.53%
Quarter Report
Latest QR
Upcoming QR
CMSB's Result
CMSB's Financial Summary
View:
Show?
TTM Result
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Revenue 1,785,141 1,791,648 1,673,898 1,602,418 1,524,751 1,479,721 1,416,841 16.70%
PBT 338,330 370,271 341,452 377,760 336,107 306,272 294,894 9.62%
Tax -75,550 -81,351 -75,844 -88,997 -83,918 -81,029 -79,346 -3.22%
NP 262,780 288,920 265,608 288,763 252,189 225,243 215,548 14.16%
-
NP to SH 214,406 239,862 221,335 242,731 211,344 185,241 175,072 14.50%
-
Tax Rate 22.33% 21.97% 22.21% 23.56% 24.97% 26.46% 26.91% -
Total Cost 1,522,361 1,502,728 1,408,290 1,313,655 1,272,562 1,254,478 1,201,293 17.15%
-
Net Worth 1,869,413 1,862,086 1,807,584 1,786,110 1,738,287 1,697,033 1,354,271 24.04%
Dividend
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Div 88,834 88,239 88,239 56,148 56,148 57,217 57,217 34.18%
Div Payout % 41.43% 36.79% 39.87% 23.13% 26.57% 30.89% 32.68% -
Equity
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Net Worth 1,869,413 1,862,086 1,807,584 1,786,110 1,738,287 1,697,033 1,354,271 24.04%
NOSH 1,074,375 1,040,271 1,038,841 1,038,436 1,034,694 339,406 338,567 116.40%
Ratio Analysis
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
NP Margin 14.72% 16.13% 15.87% 18.02% 16.54% 15.22% 15.21% -
ROE 11.47% 12.88% 12.24% 13.59% 12.16% 10.92% 12.93% -
Per Share
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 166.16 172.23 161.13 154.31 147.36 435.97 418.48 -46.06%
EPS 19.96 23.06 21.31 23.37 20.43 54.58 51.71 -47.07%
DPS 8.27 8.50 8.49 5.41 5.43 16.86 16.90 -37.98%
NAPS 1.74 1.79 1.74 1.72 1.68 5.00 4.00 -42.67%
Adjusted Per Share Value based on latest NOSH - 1,038,436
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 166.08 166.69 155.73 149.08 141.86 137.67 131.82 16.70%
EPS 19.95 22.32 20.59 22.58 19.66 17.23 16.29 14.50%
DPS 8.26 8.21 8.21 5.22 5.22 5.32 5.32 34.19%
NAPS 1.7392 1.7324 1.6817 1.6617 1.6172 1.5789 1.26 24.04%
Price Multiplier on Financial Quarter End Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 -
Price 5.15 4.50 3.96 4.35 3.73 9.80 6.87 -
P/RPS 3.10 2.61 2.46 2.82 2.53 2.25 1.64 53.05%
P/EPS 25.81 19.52 18.59 18.61 18.26 17.96 13.29 55.84%
EY 3.88 5.12 5.38 5.37 5.48 5.57 7.53 -35.80%
DY 1.61 1.89 2.14 1.24 1.45 1.72 2.46 -24.67%
P/NAPS 2.96 2.51 2.28 2.53 2.22 1.96 1.72 43.74%
Price Multiplier on Announcement Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 26/08/15 18/05/15 25/02/15 26/11/14 27/08/14 14/05/14 26/02/14 -
Price 4.91 5.37 4.29 4.45 4.19 9.86 7.51 -
P/RPS 2.96 3.12 2.66 2.88 2.84 2.26 1.79 39.96%
P/EPS 24.60 23.29 20.14 19.04 20.51 18.07 14.52 42.25%
EY 4.06 4.29 4.97 5.25 4.87 5.54 6.89 -29.78%
DY 1.68 1.58 1.98 1.22 1.30 1.71 2.25 -17.74%
P/NAPS 2.82 3.00 2.47 2.59 2.49 1.97 1.88 31.13%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment